Dr Richard Hopkins is the Managing Director of Zelda Therapeutics, which is a medicinal cannabis company. Alan Kohler spoke to Dr Hopkins to find out more about how they operate and the prescription cannabinoid space.
Alan Kohler is one of Australia’s most respected finance reporters. For decades readers and viewers have enjoyed his expert opinion in press, television and of course on line. His writing and interviews bring a context to the issues that matter to investors, with a personality that is often missing from other financial experts. Alan started The Constant Investor to be able to directly share his passion for discovering exciting companies.